ApoB, plaque, and when to start treating heart disease
Without an ApoB particle depositing cholesterol in the artery wall there is no atherosclerosis: it is the necessary substrate, and the single worst gene variant raises cardiovascular risk by under 50 percent while high blood pressure, smoking, or diabetes each multiply it by two to four.
- What to do: Get an Lp(a) once in a lifetime and add an ApoB to your standard lipid panel, along with blood pressure and waist size. If you have high ApoB with a bad family history, consider a low dose statin plus ezetimibe even if imaging shows no plaque.
- Why it matters: Lowering ApoB and LDL cuts events in every trial, and kept cutting them going from 70 to 15 mg/dL. Lower for longer is better, and treatment intensity should match plaque burden.
- How to apply it: Use the PREVENT calculator, which now covers ages 30 to 79 and gives a 30 year risk. A calcium score only sees calcified plaque and coronary CT angiography detects more; a clean coronary does not rule out plaque elsewhere. Re-evaluate yearly and repeat imaging in three to seven years.
- Metrics: physiologic ApoB below 40 to 50 mg/dL, the level we are born with; a threshold of about 5,000 mg/dL years of accumulated LDL cholesterol; example of taking ApoB from 90 to 60 with a low dose statin and ezetimibe; hazard ratio of the worst gene below 1.5.
- Tools: standard lipid panel, ApoB, Lp(a), PREVENT calculator, coronary calcium score, coronary CT angiography, Life's Essential 8, statins, ezetimibe, PCSK9 inhibitors, bempedoic acid.
- Exceptions: you can live to 120 with an untreated LDL of 300 mg/dL and never have an event; the isolated number predicts mainly at the extremes, not in the middle range where most people sit.